Supply Chain Research

Johnson & Johnson will invest $580 million to build two new factories in China. J&J China’s Chairman, Vladimir Makatsaria, has indicated that the Chinese government is improving intellectual property controls for healthcare products. The latter driven the U.S. government’s tariffs on Chinese exports of pharmaceuticals but have had little impact on shipments, which in total across all manufacturers surged 41.6% higher on a year earlier in the third quarter. Exports from the U.S. to China are not subject to additional duties but may fall if more U.S. manufacturers follow J&J’s localization...